Launched in 2018, Kao Data develop and operate advanced data centres for high performance computing. From our hyperscale inspired campus in the heart of the UK Innovation Corridor between London and Cambridge - we provide HPC, cloud, AI and enterprise customers with a world-class home for their compute.
We are proud to be sponsoring the Start-up of the Year Award at the 2020 Cambridge Independent Science and Technology Awards.
A Newcastle-based pre-clinical service provider has been awarded Innovate UK grant to support the global fight against COVID-19.
Innovate UK, the UK’s innovation agency has awarded Alcyomics, £50,000 to carry out critical scientific support in the production of a vaccine for Covid-19.
Used in combination with StemFit Basic feeder-free medium with iMatrix-511 laminin as extracellular matrix, StemFit® for Differentiation enables researchers to undertake clinical applications involving both expansion and differentiation of human Pluripotent Stem Cell-derived cells and tissues.
Supplied as a 5X concentrate, StemFit® for Differentiation has been formulated for use with basal cell culture medium (e.g. DMEM, RPMI 1640, DMEM/F12 etc.) and a variety of different induction factors or cytokines (including Activin A and bFGF from AMSBIO).
Norwich, UK – 21 July 2020: Leaf Expression Systems (Leaf), a contract development and manufacturing organisation specialising in plant-based expression of proteins, vaccines, enzymes and complex natural products, is pleased to announce the recent appointment of Dr. Leanne Williams as Business Development Manager. Leanne has over 10 years’ experience working in the life sciences industry in both commercial and academic settings and will lead the growth of Leaf’s pipeline by identifying and establishing commercial collaborations within the global life science industry.
Industry programme created to solve the business challenges that keep life sciences leaders and innovators up at night.
Deloitte has launched the Life Sciences Catalyst in Cambridge, a collaborative platform enabling organisations in the biotech, medtech, pharmaceutical and technology sectors, as well as prospective investors, to come together to tackle the biggest challenges facing their industries.
Cambridge, UK, 07 July 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines to help accelerate gene knockout and gene activation experiments, respectively.
AMSBIO has introduced StemFit® for Differentiation - a new chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells.
The unique chemically defined composition of StemFit® for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. Free of animal- and human-derived components, StemFit® for Differentiation can be used to eliminate the risk of immunogenic contamination.
Tokyo, Japan and London, UK, 16 July 2020 – Sosei Group Corporation (“the Company”; TSE: 4565) today announces the successful completion of an International Offering of new shares and euro-yen denominated convertible bonds due 2025 that has raised a total of approximately $200 million. Further details of the International Offering can be found in the Company announcements made on 30 June 2020.
Industry programme created to solve the business challenges that keep life sciences leaders and innovators up at night.
Deloitte has launched the Life Sciences Catalyst in Cambridge, a collaborative platform enabling organisations in the biotech, medtech, pharmaceutical and technology sectors, as well as prospective investors, to come together to tackle the biggest challenges facing their industries.
The research use only kit can be used as a simple alternative to RT-qPCR for SARS-CoV-2 analysis
IPSWICH, MA (July 6, 2020): New England Biolabs® (NEB®) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV-2 RNA. The kit serves as a simple alternative to RT-qPCR and enables visual detection of amplification of SARS-CoV-2 nucleic acid in just 30 minutes.